Zenas BioPharma, Inc. (ZBIO)
Healthcare
Biotechnology
31.40 $
-2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Zenas BioPharma, Inc. (ZBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -172 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -66 | -31 | -120 | -172 | |
| 0.1 | 0.1 | 0.1 | -1.9 | |
| 0.7 | 3.5 | 11 | 26 | |
| 8.0 | -8.0 | 25 | 1.0 | |
| 2.2 | 0.0 | 0.1 | 0.0 | |
| -2.2 | 0.0 | -31 | -252 | |
| – | – | – | 0.3 | |
| 0.0 | 20 | 0.0 | – | |
| 59 | 20 | 413 | 215 | |
| -8.5 | -10 | 263 | -209 | |
| -68 | -31 | -120 | -172 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.